Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 6/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.72 |
| ▸ | MAPT | P10636 | 6/20 | 0.72 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.72 |
| ▸ | RAB9A | P51151 | 8/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
| ▸ | F7 | P08709 | 1/20 | 0.68 |
| ▸ | F3 | P13726 | 1/20 | 0.68 |
| ▸ | C1R | P00736 | 3/20 | 0.67 |
| ▸ | ELANE | P08246 | 2/20 | 0.64 |
| ▸ | NPC1 | O15118 | 6/20 | 0.59 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | MMP2 | P08253 | 3/20 | 0.54 |
| ▸ | MMP9 | P14780 | 3/20 | 0.54 |
| ▸ | MMP8 | P22894 | 3/20 | 0.54 |
| ▸ | MMP13 | P45452 | 3/20 | 0.54 |
| ▸ | APEX1 | P27695 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31742426 | 0.95 | RAB9A (0.75) | MEN1KMT2AMAPTL3MBTL1RAB9A | |
| SCHEMBL31742425 | 0.93 | MEN1 (0.64) | MEN1KMT2AMAPTL3MBTL1RAB9A | |
| SCHEMBL11812017 | 0.93 | MAPT (0.76) | MEN1KMT2AMAPTL3MBTL1RAB9A | |
| SCHEMBL6170277 | 0.90 | MEN1 (0.60) | MEN1KMT2AMAPTL3MBTL1RAB9A | |
| SCHEMBL157666 | 0.89 | MEN1 (0.81) | MEN1KMT2AMAPTL3MBTL1RAB9A | |
| SCHEMBL31742429 | 0.88 | MAPT (0.65) | MEN1KMT2AMAPTL3MBTL1RAB9A | |
| SCHEMBL6563905 | 0.88 | RAB9A (0.78) | MEN1KMT2AMAPTL3MBTL1RAB9A | |
| SCHEMBL914201 | 0.88 | MEN1 (0.68) | MEN1KMT2AMAPTL3MBTL1RAB9A | |
| SCHEMBL31742428 | 0.85 | F7 (0.71) | MEN1KMT2AMAPTL3MBTL1RAB9A | |
| SCHEMBL31742427 | 0.85 | MEN1 (0.67) | MEN1KMT2AMAPTL3MBTL1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8304538-B2 | Method of producing benzoxazinone-based compound | FUJIFILM CORPORATION (JP) | 2012-11-06 | — | — | US | disclosed |
| US-8304538-B2 | Method of producing benzoxazinone-based compound | FUJIFILM CORPORATION (JP) | 2012-11-06 | — | — | US | disclosed |
| US-20110015314-A1 | ULTRAVIOLET ABSORBENT AND PRODUCTION METHOD OF THE SAME | FUJIFILM CORPORATION (JP) | 2011-01-20 | — | — | US | disclosed |
| US-20110015314-A1 | ULTRAVIOLET ABSORBENT AND PRODUCTION METHOD OF THE SAME | FUJIFILM CORPORATION (JP) | 2011-01-20 | — | — | US | disclosed |
| US-20100256362-A1 | METHOD OF PRODUCING BENZOXAZINONE-BASED COMPOUND | FUJIFILM CORPORATION (JP) | 2010-10-07 | — | — | US | disclosed |
| US-20100256362-A1 | METHOD OF PRODUCING BENZOXAZINONE-BASED COMPOUND | FUJIFILM CORPORATION (JP) | 2010-10-07 | — | — | US | disclosed |
| WO-2009041715-A1 | METHOD OF PRODUCING BENZOXAZINONE-BASED COMPOUND | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | WO | disclosed |
| EP-0993965-B1 | Thermally sensitive recording medium | JUJO PAPER CO LTD (JP) | 2004-03-31 | — | — | EP | disclosed |
| US-6440897-B1 | BIS-BENZOXAZINONE COMPOUND AS AN ULTRAVIOLET RAY ABSORBING AGENT | NIPPON PAPER INDUSTRIES CO LTD (JP) | 2002-08-27 | — | — | US | disclosed |
| EP-0993965-A2 | Thermally sensitive recording medium | NIPPON PAPER INDUSTRIES CO., LTD. (JP) | 2000-04-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015314-A1 | ULTRAVIOLET ABSORBENT AND PRODUCTION METHOD OF THE SAME | SLC40A1, F2, SLC19A1 | MEN1 108/4885KMT2A 3141/4885MAPT 1332/4885 |
| US-20100256362-A1 | METHOD OF PRODUCING BENZOXAZINONE-BASED COMPOUND | SDHA, CYP4X1, SDHB | MEN1 1056/4885KMT2A 1631/4885MAPT 4338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.